Cryo Cell International (CCEL) Equity Ratio (2010 - 2026)

Cryo Cell International has disclosed Equity Ratio across 17 years of filings, most recently posting 0.3 for Q1 2026.

• In Q1 2026, Equity Ratio fell 32.75% year-over-year to 0.3; the TTM figure through Feb 2026 stood at 0.3 (down 32.75% YoY), while the FY2025 annual figure was 0.3, down 47.51% from the prior year.
• Equity Ratio steadied at 0.3 in Q1 2026, from 0.3 in the prior quarter.
• Over the last five years, Equity Ratio for CCEL reached as high as 0.08 in Q2 2022 and fell as low as 0.3 in Q1 2026.
• The 5-year median for Equity Ratio is 0.17 (2024), against an average of 0.12.
• Annual changes were most pronounced in 2022 — Equity Ratio soared 581.68% — and 2024, when it plunged 65489.26%.
• A 5-year view of Equity Ratio shows it stood at 0.02 in 2022, then sank by 626.05% to 0.17 in 2023, then retreated by 19.81% to 0.2 in 2024, then tumbled by 47.51% to 0.3 in 2025, then fell by 0.26% to 0.3 in 2026.
• According to Business Quant data, Equity Ratio over the past three periods registered 0.3, 0.3, and 0.23 for Q1 2026, Q4 2025, and Q3 2025 respectively.